Heikki J Ruskoaho (Heikki Ruskoaho)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Left Ventricular

Transforming Growth Factor

Embryonic Stem Cells

Top Venues

Stem cell research & therapy

Scientific reports

Archives of toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Lotta Pohjolainen, Sini M Kinnunen, Samuli Auno, Alexandros Kiriazis, Saana Pohjavaara, Julia Kari-Koskinen, Matej Zore, Mikael Jumppanen, Jari T Yli-Kauhaluoma, Virpi Talman, Heikki J Ruskoaho, Mika J Välimäki
Switching of hypertrophic signalling towards enhanced cardiomyocyte identity and maturity by a GATA4-targeted compound. Stem cell research & therapy 15 (1) (2024)
Lotta Pohjolainen, Sini M Kinnunen, Samuli Auno, Alexandros Kiriazis, Saana Pohjavaara, Julia Kari-Koskinen, Matej Zore, Mikael Jumppanen, Jari T Yli-Kauhaluoma, Virpi Talman, Heikki J Ruskoaho, Mika J Välimäki
Switching of hypertrophic signalling towards enhanced cardiomyocyte identity and maturity by a GATA4-targeted compound. Stem cell research & therapy 15 (1) (2024)
Lotta Pohjolainen, Sini M Kinnunen, Samuli Auno, Alexandros Kiriazis, Saana Pohjavaara, Julia Kari-Koskinen, Matej Zore, Mikael Jumppanen, Jari T Yli-Kauhaluoma, Virpi Talman, Heikki J Ruskoaho, Mika J Välimäki
Switching of hypertrophic signalling towards enhanced cardiomyocyte identity and maturity by a GATA4-targeted compound. Stem cell research & therapy 15 (1) (2024)
Lotta Pohjolainen, Sini M Kinnunen, Samuli Auno, Alexandros Kiriazis, Saana Pohjavaara, Julia Kari-Koskinen, Matej Zore, Mikael Jumppanen, Jari T Yli-Kauhaluoma, Virpi Talman, Heikki J Ruskoaho, Mika J Välimäki
Switching of hypertrophic signalling towards enhanced cardiomyocyte identity and maturity by a GATA4-targeted compound. Stem cell research & therapy 15 (1) (2024)
Irena Hlushchuk, Heikki J Ruskoaho, Andrii Domanskyi, Mikko Airavaara, Mika J Välimäki
Domain-Independent Inhibition of CBP/p300 Attenuates α-Synuclein Aggregation. ACS chemical neuroscience 12 (13) (2021)
S Tuuli Karhu, Sini M Kinnunen, Marja Tölli, Mika J Välimäki, Zoltán Szabó, Virpi Talman, Heikki J Ruskoaho
GATA4-targeted compound exhibits cardioprotective actions against doxorubicin-induced toxicity in vitro and in vivo: establishment of a chronic cardiotoxicity model using human iPSC-derived cardiomyocytes. Archives of toxicology 94 (6) (2020)
Nazanin Zanjanizadeh Ezazi, Rubina Ajdary, Alexandra Correia, Ermei M Mäkilä, Jarno J Salonen, Marianna L Kemell, Jouni Hirvonen, Orlando J Rojas, Heikki J Ruskoaho, Hélder Almeida Santos
Fabrication and Characterization of Drug-Loaded Conductive Poly(glycerol sebacate)/Nanoparticle-Based Composite Patch for Myocardial Infarction Applications. ACS applied materials & interfaces 12 (6) (2020)
Mika J Välimäki, Heikki J Ruskoaho
Targeting GATA4 for cardiac repair. IUBMB life 72 (1) (2019)
Robert S Leigh, Heikki J Ruskoaho, Bogac L Kaynak
A novel dual reporter embryonic stem cell line for toxicological assessment of teratogen-induced perturbation of anterior-posterior patterning of the heart. Archives of toxicology 94 (2) (2019)
Outi Renko, Anna-Maria Tolonen, Jaana Rysä, Johanna Magga, Erja Mustonen, Heikki J Ruskoaho, Raisa Serpi
SDF1 gradient associates with the distribution of c-Kit+ cardiac cells in the heart. Scientific reports 8 (1) (2018)
Sini M Kinnunen, Marja Tölli, Mika J Välimäki, Erhe Gao, Zoltan Szabo, Jaana Rysä, Mónica P A Ferreira, Pauli Ohukainen, Raisa Serpi, Alexandra Correia, Ermei Mäkilä, Jarno J Salonen, Jouni Hirvonen, Hélder Almeida Santos, Heikki J Ruskoaho
Cardiac Actions of a Small Molecule Inhibitor Targeting GATA4-NKX2-5 Interaction. Scientific reports 8 (1) (2018)
Jaana Rysä, Heikki Tokola, Heikki J Ruskoaho
Mechanical stretch induced transcriptomic profiles in cardiac myocytes. Scientific reports 8 (1) (2018)